Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIIb, Multicenter, Open-label Study of Patients With Pulmonary Arterial Hypertension Treated With Iloprost(Inhalation)Evaluating Safety and Inhalation Times When Converting From Power Disc-6 (PD-6) to Power Disc-15 (PD-15) With the I-neb® AAD®

NCT00723554 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT00723554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00723554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIIb, Multicenter, Open-label Study of Patients With Pulmonary Arterial Hypertension Treated With Iloprost(Inhalation)Evaluating Safety and Inhalation Times When Converting From Power Disc-6 (PD-6) to Power Disc-15 (PD-15) With the I-neb® AAD®
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2008
Completion date
April 30, 2011
Enrollment
63 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension